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The amino acid sequence of a region on the gly~g~-bin~ng (G~sub~it of protein phosphat~l~ that 
is phosphorylat~ by cyclic AMPde~ndent pr&ein kinase has been determined. The sequence is: 
P 
KPGFSPQPSRRGSESSEEVYVHTASSGGR 
This finding will facilitate studies of the effects of hormones on the phosphorylation state of the G-subunit 
in vivo. 
Glycogen metabolism cyclic AMP Protein phosphorylation Protein phosphatase 
1. INTRODUCTION 
Protein phosphatases in the cytoplasm of mam- 
malian cells that are capable of dephosphorylating 
seryl and threonyl residues have been classified in- 
to two types. Type-l protein phosphatases dephos- 
phorylate the &subunit of phosphorylase kinase 
preferentially and are inhibited by the ther- 
mostable proteins inhibitor-l and inhibitor-2, 
while type-2 protein phosphatases dephosphorylate 
the cr-subunit of phospho~l~e kinase preferen- 
tially and are insensitive to inhibitors-l and -2 
[1,2]. 
Two type-l protein phosphatases have been 
purified to homogeneity from rabbit skeletal mus- 
cle, termed protein phosphatase-lr and protein 
phosphatase-lo [3]. Protein phosphatase-lr, also 
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termed the Mg-ATP~e~ndent protein phospha- 
tase [4], is an inactive species that consists of a 
37 kDa catalytic (C)-subunit and inhibitor-2 in a 
1: 1 molar ratio [5-81. Activation of protein phos- 
phatase-lr is triggered by the phosphorylation of 
inhibitor-2 on a threonyl residue [5,8], catalysed by 
a protein kinase termed glycogen synthase kinase3 
[9,10] or Factor F, 141. 
A major proportion of the protein phosphatase- 
lo in rabbit skeletal muscle is bound to glycogen. 
This species is composed of a 37 kDa catalytic (C)- 
subunit and a 103 kDa glycogen-binding (G)- 
subunit in a 1: 1 molar ratio [3]. The C-subunits of 
protein phosphatase-lr and protein phosphatase-lc; 
appear to be identical, as judged by peptide map- 
ping [3,7,1 I]. 
Recently, we reported that protein phosphatase- 
1~ was an excellent substrate for cyclic AMP- 
dependent protein kinase in vitro. Its initial rate of 
phosphorylation was similar to that of glycogen 
synthase, a well established physiological substrate 
of this protein kinase, and near stoichiometric 
~bi~hed by Etsevier Science Publ~he~ B. K ~Biomed~cai Djv~ion) 
00145793/86/$3.50 0 1986 Federation of European Biochemical Societies 85 
Volume 194, number 1 FEBS LETTERS January 1986 
phosphorylation of the G-subunit could be 
achieved f3]. The covalently bound phosphate was 
attached to a seryl residue(s) [3]. 
Here, the amino acid sequence surrounding the 
phosphorylation site on the G-subunit of protein 
phosphatase-lo has been determined. This infor- 
mation will facilitate analysis of the phosphoryla- 
tion state of this protein in vivo, and further 
analysis of its physiological role(s). 
2. MATERIALS AND METHODS 
2.1. Protein preparaiio~s 
Protein phosphatase-lo [3] and the catalytic 
subunit of cyclic AMP-dependent protein kinase 
[12] were purified from rabbit skeletal muscle. 
Trypsin (treated with tosylphenyl chloromethyl 
ketone) and chymotrypsin (3 times crystallised) 
were products of Worthington, purchased from 
Cambrian Chemicals (Croydon, England). 
2.2. Phosp~oryiatio~ 0~ protein p~osphatase-~~ 
Protein phosphatase-lo (5 mg) was incubated 
for S-10 min at 30°C with cyclic AMP-de~ndent 
protein kinase (20 U; see 1131 for definition of 
units) in 25 mM sodium glycerol-l-phosphate, 
4 mM magnesium acetate and 0.1 mM [Y-~~P]ATP 
(6 x 10’ cpm/pmol). The total volume was 20 ml. 
The solution was made 5 mM in EDTA, 10 mM in 
sodium pyrophosphate and 80 mM in sodium 
fluoride to terminate the phosphorylation reaction 
and prevent dephosphorylation. The solution was 
concentrated to 1-2 ml by vacuum dialysis at 4°C 
and dialysed for a further 20 h at 4°C against 25 
mM sodium glycerol-l-phosphate, 1 .O mM EDTA, 
10 mM sodium pyrophosphate, 80 mM sodium 
fluoride, 0. f 9‘0 2-mercaptoethanol, pH 7.0. After 
dialysis, residual fy-32P]ATP comprised 25-30070 
of the 32P radioactivity, the remainder being 
protein-bound. This solution was digested with 
either trypsin or chymotrypsin as described in sec- 
tion 3. 
3. RESULTS 
3.1. isolation and st~ct~re of the tryptic 
phospho~ptide 
32P-labelled protein phosphatase-lo (1.1 ml, 4 
mg/ml) containing 0.9 mol phosphate/m01 G- 
86 
subunit in 25 mM sodium glycerol-l-phosphate, 
1 .O mM EDTA, 10 mM sodium pyrophosphate, 80 
mM NaF, 0.1070 (v/v) 2-mercaptoethanol, pH 7.0, 
was incubated with trypsin (0.11 ml, 1 .O mg/ml) 
for 10 min at 30°C. The digestion was terminated 
by addition of 0.07 ml of 100% (w/v) 
trichloroacetic acid, and after standing in ice for 5 
min, the suspension was centrifuged for 2 min at 
13 000 x g. The supernatant was collected, and the 
pellet re-extracted with 0.3 ml of 5% (w/v) 
trichloroacetic acid, and recentrifuged. The com- 
bined trichloroacetic acid supernatants, containing 
>!Xl% of the 32P radioactivity, were extracted 
three times with ether to remove trichloroacetic 
acid, made 0.2 M in NHeHCO3 and redigested for 
16 h at 37’C with 25 pg trypsin. The solution was 
then subjected to gel filtration on Sephadex G-50 
superfine (Pharmacia) as described in the legend to 
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Fig.1. Gel-filtration on Sephadex G-50 (superfine) of 
trichloroacetic a id-soluble 32P radioactivity released by 
brief tryptic digestion of native protein phosphatase-lq. 
32P-labelled enzyme was digested with trypsin and 
prepared for ge1 filtration as described in the text. The 
sample (1.5 ml) was applied to the column (120 x 1.3 cm) 
equilibrated at 20°C in 0.1 M NHdHC03. The flow rate 
was 10 ml/h and fractions of 1.15 ml were collected, The 
horizontal bar indicates the fractions pooled after elu- 
tion. The minor peak corresponds to [y-“P]ATP. The 
void volume was at fraction 1. 
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fig. 1. 32P radioactivity was recovered from the col- 
umn as a major peak ( l’e/v~ = 2.3) and a minor 
peak ( ve’e/Vo = 2.89, the latter corresponding to 
[y-32P]ATP that had been incompletely removed 
by dialysis (section 2.2). 
The major radioactive peak from Sephadex 
G-50 was dried in a vacuum concentrator (Savant 
Instruments), dissolved in 0.1% (v/v) trifluoro- 
acetic acid (TFA) and subjected to reverse-phase 
HPLC using a Vydac Crs column (Separations 
Group, CA) as described in the legend to fig.2. ‘*P 
radioactivity was separated by HPLC into two 
peaks that were just resolved from one another 
(fig.2). The major component Tl (85%) eluted just 
after the minor component T2 (15%), and both 
radioactive species coincided with peaks of 206 nm 
absorbance (fig.2). 
The composition of peptide Tl is shown in table 
1. A sample of Tl (4 nmol) was analysed on a 
Beckman sequencer as described in the legend to 
fig.3, and its complete primary structure was 
established by this technique. The analysis was 
repeated using a second aliquot of peptide Tl with 
identical results. The sequence of the peptide was 
found to be: 
R-G-S-E-S-S-E-E-V-Y-V-H-T-A-S-S-G-G-R. 
80 - 
10 20 30 40 50 60 70 
time (min) 
Fig.2. Fractionation of the major tryptic phosphopep- 
tide from Sephadex G-50 (fig. 1) on a Vydac Crs column. 
Reverse-phase chromatography was carried out using a 
Gilson HPLC system equipped with an ultraviolet detec- 
tor (Gilson) and a radioactive on-line monitor (Reeve 
Analytical). The delay time between the detectors was 1 
min. The full line shows absorbance at 206 nm; and the 
broken line 32P radioactivity in arbitrary units. The col- 
umn was developed with a water/acetonitrile gradient 
(O-40%) containing 0.1% (v/v) TFA, with an increase in 
acetonitrile concentration of 0.3% per min (-). No 
Tryptic peptides commencing with arginine have 
been isolated from many proteins phosphorylated 
by cyclic AMP-dependent protein kinase, because 
the sequence Arg-X-Ser(P) is resistant o tryptic at- 
tack (e.g. [14,15]). This suggested that Ser-3 was 
the site of phosphorylation, an idea confirmed by 
the ‘burst’ of 32P radioactivity observed after the 
third cycle of Edman degradation (fig.3). The 
thiazolinone derivative of phosphoserine is un- 
stable and breaks down rapidly to yield inorganic 
phosphate, which is poorly extracted from the se- 
quencer cup by the organic solvents employed. 
Hence the burst of radioactivity is not quantitative 
and a ‘trail’ of radioactivity occurs at subsequent 
cycles due to continued extraction of traces of in- 
organic phosphate [ 161. 
radioactivity was eluted after 80 min. Although the quantity of peptide T2 was too low 
Table 1 
Amino acid compositions of peptides Tl, Cl and C2 
Amino acid Amount in 
Tl Cl c2 
Asx 0.25(O) 0.64(O) 0.46(O) 
Glx 3.28(3) 4.01(4) 4.33(4) 
Ser 4.71(5) 4.60(5) 5.13(5) 
Gly 3.24(3) 2.09(2) 2.1 l(2) 
His 0.55(l) 
Arg 2.00(2) 1.80(2) 1.19(2) 
Thr 0.79(l) 0.34(O) 
Ala 1.05(l) 0.37(O) 
Pro 2.91(3) 3.00(3) 
T yr 0.80( 1) 0.62(l) 0.70( 1) 
Val 1.64(2) 0.62( 1) 0.79( 1) 
Met 
Be 
Leu 0.32(O) 
Phe 0.86( 1) 0.85(l) 
LYS 1.10(l) 1.15(l) 
Total 19 20 20 
Peptides were hydrolysed in Pyrex tubes for 18 h at 
llO°C in the presence of 6 M HCI and 2 mM phenol. 
The hydrolysates were dried, converted to phenyl- 
thiocarbamyl derivatives and analysed on a Waters 
PICOTAG amino acid analysis system. Serine and 
threonine were corrected for 10 and 5% destruction, 
respectively and impurities below 0.2 mol are omitted. 
Numbers in parentheses indicate residues determined by 
sequencer analysis 
87 
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peptide Tl 
peptide C2 
1 
Fig.3. Sequencer analysis of peptide Tl and peptide C2. 
Tryptic peptide Tl from fig.2 (4 nmol, 95 000 cpm) and 
chymotryptic peptide C2 from fig.4 (4 nmol, 60000 
cpm) were analysed on a Beckman 890D sequencer using 
a 0.1 M quadrol programme, with a single coupling 
followed by a double cleavage. Polybrene (3 mg) was 
added in aqueous solution to the spinning cup and dried 
down as a film. Conversion to phenylthiohydantoins 
was by incubation with 20% (w/v) TFA, 0.02% (w/v) 
dithioerythrytol for 8 min at 80°C. The figure shows 32P 
radioactivity extracted from the sequencer cup at each 
cycle of Edman degradation measured by Cerenkov 
counting and residues detected by HPLC analysis of the 
phenylthiohydantoin derivatives [ 181. The average 
repetitive yield per cycle was 94% for both peptides. 
for an accurate amino acid analysis, its composi- 
tion was very similar to that of T2 (not shown). 
Furthermore, when T2 (0.5 nmol) was subjected to 
sequencer analysis, its first 14 residues could be 
assigned unambiguously and were identical to 
those of peptide Tl. The relationship between Tl 
and T2 is considered further in section 4. The 
overall recovery of peptides Tl and T2 from the 
starting material was 45%. 
3.2. Isolation and structure of a chymotryptic 
phosphopeptide 
The finding that tryptic peptide Tl commenced 
with the sequence Arg-Gly-Ser(P) indicated the 
presence of two adjacent basic residues immediate- 
ly N-terminal to the phosphoserine, acharacteristic 
of many of the best substrates for cyclic AMP- 
dependent protein kinase (reviewed [17]). In order 
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to extend the sequence of peptide Tl in the N- 
terminal direction, a second preparation of 32P- 
labelled protein phosphatase-lo was digested with 
chymotrypsin. The initial steps of purification, up 
to and including gel-filtration on Sephadex G-50 
were identical to those described in section 3.1, ex- 
cept that chymotrypsin (1 .O mg/ml) replaced tryp- 
sin (1.0 mg/ml). As observed with trypsin, brief 
chymotryptic attack of the native enzyme released 
>95% of the protein-bound radioactivity as 
trichloroacetic acid-soluble peptides within 10 min. 
Three 32P-labelled peptides were eluted from 
Sephadex G-50, a major component at I’,/Vo of 
2.25 and two minor components at V,/Vo of 2.4 
and 2.65. A fourth peak at V,/VO = 2.9 cor- 
responded to [Y-~~P]ATP. The major peak ( I’,/ VO 
= 2.25) was dried, redissolved in 0.1% (v/v) TFA 
and subjected to reverse-phase HPLC (fig.4). This 
fraction was separated by HPLC into two 32P- 
labelled peaks, Cl and C2, that were just resolved 
from one another. The two radioactive species 
were present in similar amounts and coincided with 
peaks of ultraviolet absorbance. 
The amino acid compositions (table 1) and 
primary structures of peptides Cl and C2 were 
identical and their possible relationship is con- 
sidered further in section 2. Both peptides were se- 
Cl c2 
L A & ’ I : 1 ______ - -._________-__-I ‘, .______ 
01 I I I I I I I I 
40 50 60 
time (min) 
1 c 
Fig.4. Fractionation of the major chymotryptic peptide 
from Sephadex G-50 on a Vydac Cl8 column. HPLC was 
carried out as described for the tryptic peptides (fig.2). 
The full line shows absorbance at214 nm and the broken 
line ‘*P radioactivity in arbitrary units. Note the 1 min 
delay between the ultraviolet and radioactive detectors 
(see fig.2). No radioactivity was eluted before 40 min or 
after 60 min. 
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quenced to their C-termini, and their primary 
structures were found to be: 
K-P-G-F-S-P-Q-P-S-R-R-G-S-E-S-S-E-E-V-Y 
The last 10 residues were identical to the first 10 
residues of peptides Tl and T2, and a burst of 32P 
radioactivity was observed at the 13th cycle, as ex- 
pected (fig.3). This established the presence of two 
adjacent arginyl residues N-terminal to the phos- 
phorylation site, and demonstrated that one of the 
sites of chymotryptic attack was the Tyr-Val bond 
between residues 10 and 11 of peptides Tl and T2. 
4. DISCUSSION 
The results of tryptic digestion demonstrate that 
the G-subunit is phosphorylated by cyclic AMP- 
dependent protein kinase at one major site. How- 
ever, following either tryptic or chymotryptic 
digestion two phosphopeptides were separated by 
reverse-phase HPLC (figs 2 and 4) that had iden- 
tical compositions, specific radioactivities (cpm/ 
nmol) and primary structures. Why these peptides 
were resolved into two forms is unclear. One 
possibility is that a second seryl residue in the pep- 
tide was already partially phosphorylated even 
before incubation with cyclic AMP-dependent pro- 
tein kinase and Mg-ATP. We have observed that 
diphosphorylated forms of peptides are eluted 
from reverse-phase HPLC columns earlier than 
monophosphorylated peptides, and that mono- 
phosphorylated species frequently elute just before 
the dephosphorylated forms (unpublished). If this 
suggestion is correct, it would imply that the G- 
subunit is a target for at least two protein kinases. 
The sequence Arg-Arg-X-Ser is common to 
many of the best substrates for cyclic AMP- 
dependent protein kinase, and it is well established 
that the adjacent arginyl residues play a key role in 
substrate recognition (reviewed in [17]). This ex- 
plains why protein phosphatase-lo is phosphoryl- 
ated at a similar rate to glycogen synthase [3]. 
However, the presence of several acidic residues 
immediately C-terminal to the phosphoserine is 
unusual [17]. We have previously suggested that 
acidic residues C-terminal to phosphorylation sites 
may act as negative specificity determinants for 
protein phosphatases [l]. Thus the three glutamyl 
residues may play an important role in decreasing 
the rate at which the G-subunit is dephosphorylated 
by the C-subunit, thereby prolonging the biolo- 
gical effects of phosphorylation. 
The G-subunit is extraordinarily susceptable to 
proteolysis. Despite the inclusion of several pro- 
teinase inhibitors and a rapid purification pro- 
cedure [3], the G-subunit is undetectable by SDS- 
polyacrylamide gel electrophoresis in a number of 
preparations, even though the C-subunit appears 
completely undegraded [3]. However, such prepar- 
ations are phosphorylated by cyclic AMP-depen- 
dent protein kinase in an identical manner to un- 
degraded preparations of protein phosphatase-lo. 
Following phosphorylation, SDS-polyacrylamide 
gel electrophoresis of degraded preparations 
reveals a multiplicity of “P-1abelled bands 
(sometimes more than 25) ranging in apparent 
molecular mass from 100 kDa to ~20 kDa. These 
bands are derived from the G-subunit, since they 
are immunoprecipitated by antibodies raised 
against the undegraded G-subunit (purified by 
SDS-polyacrylamide gel electrophoresis), but not 
by preimmune IgG. Similarly, tryptic digestion 
of degraded preparations generates a single 
19-residue phosphopeptide, i.e. the tryptic 
phosphopeptide described in this paper (not 
shown). Such extensive fragmentation of the G- 
component presumably explains the failure to 
detect this subunit, until recently. Nevertheless, 
despite the cleavage of many peptide bonds, the 
fragments of the G-subunit must interact with one 
another and with the C-subunit, since the gel- 
filtration behaviour of degraded and undegraded 
preparations is very similar (unpublished). 
Two roles for the G-subunit in the regulation of 
protein phosphatase-1 have so far been identified. 
Firstly, the G-subunit is the component responsible 
for targetting the C-subunit to the glycogen- 
protein particles [3]. Secondly, phosphorylation of 
the G-subunit by cyclic AMP-dependent protein 
kinase increases the rate at which the G-subunit 
can be inactivated by inhibitor-l. Since inhibitor-l 
is only inhibitory if phosphorylated by cyclic 
AMP-dependent protein kinase (reviewed in [2]), 
phosphorylation of the G-subunit may amplify the 
effects of cyclic AMP. Investigation of the in vivo 
phosphorylation state of the G-subunit will be 
necessary to evaluate the physiological significance 
of this control mechanism. The results presented 
here will facilitate this analysis. 
89 
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